Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study of Nexavar for Neoadjuvant Treatment of Anaplastic Thyroid Cancer

NCT03565536 is registered in ClinicalTrials.gov with Fujian Medical University as lead sponsor.

NCT NCT03565536
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03565536 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study of Nexavar for Neoadjuvant Treatment of Anaplastic Thyroid Cancer
Lead sponsor
Fujian Medical University
Phase
Phase 2
Overall status
Completed
Start date
May 1, 2018
Completion date
December 30, 2020
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thyroid cancer, anaplastic